This announcement is a separate document:
灵康药业集团股份有限公司主体及“灵康转债”2022年度跟踪评级报告
Lingkang Pharmaceutical Group Co., Ltd. principal and “Lingkang Convertible Bonds” 2022 tracking rating report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated